Healthcare >> Analyst Interviews >> October 26, 2004
SMALL TO MID-CAP BIOTECHNOLOGY COMPANIES: NAVDEEP JAIKARIA – RODMAN & RENSHAW INC
NAVDEEP S. JAIKARIA joined Rodman & Renshaw, Inc., as a Senior
Biotechnology Analyst in July 2003. Previously, Dr. Jaikaria was a
Senior Biotechnology Analyst covering small and mid-cap biotechnology
companies at Leerink Swann & Company as well as Mehta Partners. Dr.
Jaikaria obtained his PhD at New York Medical College in Cell Biology
and Anatomy and conducted postdoctoral research at The Rockefeller
University. His scientific research focused on infectious diseases and
cancer. Before joining Wall Street, Dr. Jaikaria also served as a
consultant to biotechnology and pharmaceutical companies. Profile
TWST: Navdeep, would you please give us a quick overview of what you're
covering in the biotech space?
Mr. Jaikaria: My coverage focuses on small to mid-cap biotechnology